COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
seasonshare Welcomes Former MLB Executive Brian Richeson as Executive Vice President of Business Development
seasonshare, the leading customizable ticketing technology platform in the sports and entertainment industry, announces the addition of Brian Richeson as the Executive Vice President of Business Development. Richeson, a veteran sales executive with over two decades of experience in the professional sports industry, will spearhead innovative sales strategies, nurture corporate relationships, and drive forward initiatives that resonate with fans and stakeholders alike -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: 029 Group SE: Successful Exit of Stake in Portfolio Company Emerald Stay
029 Group SE successfully exits stake in Emerald Stay S.A., generating approx. EUR 1.6 mn. Transaction reflects 2.3X multiple on FY 2023 book value. Company continues exposure to Emerald Stay through investment in Limestone Capital AG -
COMMUNIQUÉ DE PRESSE
Vicinity Motor Corp. Secures Follow-On Order for 12 Vicinity(TM) Classic Buses from La Québécoise
Vicinity Motor Corp. receives follow-on purchase order for 12 Vicinity™ Classic buses from Autobus La Québécoise to service multiple cities in Quebec. Order validates market leadership in Canadian mid-sized heavy duty segment -
COMMUNIQUÉ DE PRESSE
Monogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual Meeting
Monogram Orthopaedics Inc. featured its mBôs commercial robot and mVision technologies in a discussion with a panel of orthopaedic surgeons. The company intends to present at the 2024 Canaccord Genuity Musculoskeletal Conference and attend the AAOS Annual Meeting. Monogram aims to combine personalized knee implants with precision robotic surgical assistants for better-fitting knee replacements. Investor relations contact: Chris Tyson, MZ North America, 949-491-8235, MGRM@mzgroup.us -
COMMUNIQUÉ DE PRESSE
Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea
Jaguar Health announces Orphan Drug Designation application for crofelemer for symptomatic relief and treatment of moderate-to-severe diarrhea caused by bacterial, viral, and parasitic infections, including cholera. Crofelemer is a novel plant-based prescription drug derived from the red bark sap of the medicinal Croton lechleri tree in the Amazon Rainforest -
-
COMMUNIQUÉ DE PRESSE
CORRECT AND REPLACE: GEE Group to Hold Investor Conference Call to Discuss 2024 Fiscal First Quarter Results
GEE Group Inc. will hold an investor webcast/conference call on February 14, 2024, to discuss its December 31, 2023 Fiscal First Quarter results. The call will be available for viewing and listening via the provided webcast link -
-
COMMUNIQUÉ DE PRESSE
Spoutible to Host Groundbreaking Virtual Town Hall With Guest Speaker U.S. Rep. Jasmine Crockett
Spoutible to host interactive virtual town hall with U.S. Rep Jasmine Crockett and Kimberley Johnson, discussing the intersection of technology and politics, using innovative Spoutible Pods platform
